Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris
| Status: | Completed |
|---|---|
| Conditions: | Acne, Acne, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 12 - 45 |
| Updated: | 5/25/2018 |
| Start Date: | September 25, 2017 |
| End Date: | April 10, 2018 |
A Prospective, Multicenter, Randomized, Controlled, Evaluator-Blinded Study of the Safety and Effectiveness of Sebacia Microparticles as an Accessory to 1064 nm Nd:Yag Laser in the Treatment of Facial Inflammatory Acne Vulgaris
Prospective, randomized, controlled, parallel group clinical study with blinded assessment
evaluating Sebacia Microparticles (SM) with Nd:Yag laser in facial inflammatory acne vulgaris
evaluating Sebacia Microparticles (SM) with Nd:Yag laser in facial inflammatory acne vulgaris
Inclusion Criteria:
- Mild to moderate acne vulgaris
- At least 15 inflammatory acne lesions
- Skin phototype I - III
- Able to understand and comply with study requirements
Exclusion Criteria:
- Severe acne vulgaris
- Nodulocystic acne
- Ongoing use of medications and/or treatments for acne
- New hormone regimen (used for less than 12 weeks)
- Significant medical or mental health condition
We found this trial at
11
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Wake Research Associates, LLC Wake Research is an Organization of Unified Investigational Sites working closely...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials